Andrew H. Talal

Professor
Department of Medicine
Buffalo VA Medical Center
United States of America

Professor Gastroenterology
Biography

Andrew H. Talal is a leading expert in liver disease. His work through UBMD at Erie County Medical Center’s liver clinic has tripled the clinic’s capacity to treat patients with viral hepatitis and other forms of liver disease. In addition, he provide clinical support to the Buffalo VA Medical Center in order to deliver uniformly excellent clinical care to patients with liver disease cared for at hospitals and clinics affiliated with UB’s medical school. Education and Training: Research Associate & Clinical Scholar, The Rockefeller University, Aaron Diamond AIDS Research Center (2000), Fellowship, Medicine, Division of Gastroenterology, University of North Carolina (1996), MPH, Epidemiology, University of North Carolina (1996), Fellowship, Medicine, University of North Carolina (1995), Internship, Internal Medicine, University of Iowa (1993), MD, Internal Medicine, University of Texas Health Science Center (1990). He offer trial therapies to patients with viral hepatitis and other forms of liver disease if they meet the protocol criteria of our clinical trials. Our patient-care efforts include digital outreach: my colleagues and I co-authored an article for the inaugural issue of the patient-oriented online magazine “HCV Next.” Awards and Honors: Buffalo's Health Care 50 (2013), Clinical Infectious Diseases Award (2010), Clinton Global Initiatives Award, William Clinton Foundation (2006).

Research Intrest

Gastroenterology; Infectious Disease; Liver (Hepatology)

List of Publications
Wan DW, Marks K, Yantiss RK, Talal AH. Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma. AIDS patient care and STDs. 2009 Jun 1;23(6):407-13.
Jackson CB, Varon J, Ho A, Marks KM, Talal AH, Kreek MJ. Identification of substance use and dependence among patients with viral hepatitis. Digestive and Liver Disease. 2010 Sep 30;42(9):650-6.
Zeremski M, Dimova R, Astemborski J, Thomas DL, Talal AH. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C. Journal of Infectious Diseases. 2011 Sep 15;204(6):832-6.